Nifty
Sensex
:
:
22376.40
73788.72
40.00 (0.18%)
700.39 (0.96%)

Chemicals

Rating :
52/99

BSE: 524640 | NSE: Not Listed

44.52
22-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  47.10
  •  47.20
  •  43.70
  •  46.63
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  228
  •  9.87
  •  77.15
  •  35.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 91.36
  • 27.96
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 119.94
  • 1.12%
  • 1.53

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 63.26%
  • 0.82%
  • 32.67%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 3.25%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.01
  • 8.75
  • 10.58

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 25.69
  • -
  • 11.31

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 34.27
  • -
  • 31.64

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 109.50
  • 87.60
  • 226.84

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.16
  • 0.25
  • 0.39

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 40.44
  • 42.17
  • 56.56

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
24.81
22.42
10.66%
26.39
28.46
-7.27%
31.00
30.35
2.14%
46.55
26.29
77.06%
Expenses
23.71
18.84
25.85%
24.28
23.23
4.52%
27.75
23.18
19.72%
43.64
21.86
99.63%
EBITDA
1.10
3.58
-69.27%
2.11
5.23
-59.66%
3.25
7.17
-54.67%
2.91
4.43
-34.31%
EBIDTM
4.44%
15.96%
7.99%
18.36%
10.48%
23.63%
6.25%
16.86%
Other Income
0.52
0.19
173.68%
0.54
0.17
217.65%
0.65
0.21
209.52%
1.29
0.42
207.14%
Interest
0.77
0.52
48.08%
0.65
0.32
103.12%
0.53
0.86
-38.37%
0.51
0.67
-23.88%
Depreciation
1.49
1.31
13.74%
1.49
1.17
27.35%
1.19
1.20
-0.83%
1.16
1.23
-5.69%
PBT
-0.64
3.59
-
0.51
3.91
-86.96%
2.18
5.33
-59.10%
2.53
2.96
-14.53%
Tax
-0.18
1.36
-
0.14
0.85
-83.53%
0.60
1.21
-50.41%
0.59
1.08
-45.37%
PAT
-0.46
2.23
-
0.37
3.06
-87.91%
1.57
4.12
-61.89%
1.94
1.87
3.74%
PATM
-1.84%
9.96%
1.39%
10.75%
5.08%
13.58%
4.16%
7.13%
EPS
-0.22
1.09
-
0.18
1.49
-87.92%
0.77
2.01
-61.69%
0.94
0.91
3.30%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 08
Mar 07
Net Sales
128.75
127.78
20.81
18.66
Net Sales Growth
19.75%
514.03%
11.52%
 
Cost Of Goods Sold
90.60
75.77
15.27
14.53
Gross Profit
38.15
52.01
5.53
4.13
GP Margin
29.63%
40.70%
26.57%
22.13%
Total Expenditure
119.38
108.89
19.94
17.75
Power & Fuel Cost
-
5.55
0.47
0.34
% Of Sales
-
4.34%
2.26%
1.82%
Employee Cost
-
7.37
0.43
0.45
% Of Sales
-
5.77%
2.07%
2.41%
Manufacturing Exp.
-
11.16
0.73
0.62
% Of Sales
-
8.73%
3.51%
3.32%
General & Admin Exp.
-
1.99
0.24
0.21
% Of Sales
-
1.56%
1.15%
1.13%
Selling & Distn. Exp.
-
5.47
2.66
1.55
% Of Sales
-
4.28%
12.78%
8.31%
Miscellaneous Exp.
-
1.58
0.13
0.05
% Of Sales
-
1.24%
0.62%
0.27%
EBITDA
9.37
18.89
0.87
0.91
EBITDA Margin
7.28%
14.78%
4.18%
4.88%
Other Income
3.00
1.86
0.61
0.17
Interest
2.46
2.21
0.51
0.34
Depreciation
5.33
4.83
0.23
0.21
PBT
4.58
13.71
0.74
0.53
Tax
1.15
4.01
0.36
0.03
Tax Rate
25.11%
26.11%
48.65%
5.66%
PAT
3.42
11.35
0.38
0.50
PAT before Minority Interest
3.42
11.35
0.38
0.50
Minority Interest
0.00
0.00
0.00
0.00
PAT Margin
2.66%
8.88%
1.83%
2.68%
PAT Growth
-69.68%
2,886.84%
-24.00%
 
EPS
1.67
5.54
0.19
0.24

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 08
Mar 07
Shareholder's Funds
61.78
3.19
2.82
Share Capital
20.52
3.03
3.03
Total Reserves
41.25
0.15
-0.21
Non-Current Liabilities
16.49
7.16
3.94
Secured Loans
14.20
5.15
2.79
Unsecured Loans
0.00
1.72
1.16
Long Term Provisions
0.10
0.00
0.00
Current Liabilities
46.18
3.12
3.46
Trade Payables
21.28
2.41
3.24
Other Current Liabilities
8.61
0.63
0.21
Short Term Borrowings
11.46
0.00
0.00
Short Term Provisions
4.84
0.07
0.01
Total Liabilities
124.45
13.47
10.22
Net Block
50.43
3.00
2.90
Gross Block
69.43
4.69
4.36
Accumulated Depreciation
19.00
1.69
1.46
Non Current Assets
72.23
3.03
2.90
Capital Work in Progress
16.42
0.02
0.00
Non Current Investment
3.65
0.00
0.00
Long Term Loans & Adv.
1.73
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
Current Assets
52.06
10.44
7.33
Current Investments
0.00
0.00
0.00
Inventories
3.38
1.76
0.89
Sundry Debtors
37.36
5.89
5.06
Cash & Bank
5.13
0.55
0.22
Other Current Assets
6.20
0.00
0.00
Short Term Loans & Adv.
5.84
2.24
1.16
Net Current Assets
5.88
7.32
3.87
Total Assets
124.29
13.47
10.23

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 08
Mar 07
Cash From Operating Activity
19.49
-1.89
1.19
PBT
15.36
0.74
0.53
Adjustment
4.22
0.57
0.33
Changes in Working Capital
3.06
-3.14
0.35
Cash after chg. in Working capital
22.64
-1.83
1.21
Interest Paid
0.00
0.00
0.00
Tax Paid
-3.15
-0.06
-0.01
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
-13.57
-0.36
-0.31
Net Fixed Assets
-78.51
-0.35
Net Investments
-3.62
0.00
Others
68.56
-0.01
Cash from Financing Activity
-6.14
2.58
-0.80
Net Cash Inflow / Outflow
-0.22
0.33
0.09
Opening Cash & Equivalents
5.35
0.22
0.14
Closing Cash & Equivalent
5.13
0.55
0.22

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 08
Mar 07
Book Value (Rs.)
30.10
5.54
4.90
ROA
16.46%
3.18%
4.93%
ROE
34.94%
12.55%
17.88%
ROCE
34.18%
14.76%
12.90%
Fixed Asset Turnover
3.45
4.76
4.45
Receivable days
61.76
92.84
95.19
Inventory Days
7.34
22.48
16.76
Payable days
57.07
51.96
67.03
Cash Conversion Cycle
12.04
63.37
44.92
Total Debt/Equity
0.50
2.16
1.40
Interest Cover
7.95
2.45
2.57

Top Investors:

News Update:


  • Archit Organosys gets nod to divest entire 50.01% stake in Novel and Nano Xtreme Solutions
    27th Mar 2024, 16:02 PM

    The Board of Directors of the Company at its meeting held on March 27, 2024 has approved the same

    Read More
  • Archit Organosys - Quarterly Results
    14th Feb 2024, 18:28 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.